このページの翻訳は実験的なもので、現在開発中です。 フィードバックを お待ちしております !
Siloam International Hospitals 過去の業績 Siloam International Hospitalsは、平均年間53.6%の収益成長を遂げていますが、 Healthcare業界の収益は、年間 成長しています。収益は、平均年間9% 12.5%収益成長率で 成長しています。 Siloam International Hospitalsの自己資本利益率は12.6%であり、純利益率は8.4%です。
主要情報 Healthcare 業界の成長 14.1% 収益成長率 12.5% 株主資本利益率 13.2% ネット・マージン 8.6% 前回の決算情報 30 Jun 2024
最近の業績更新
Second quarter 2024 earnings released: EPS: Rp23.16 (vs Rp19.55 in 2Q 2023) Aug 02
Full year 2023 earnings released: EPS: Rp93.27 (vs Rp53.74 in FY 2022) Mar 28
Third quarter 2023 earnings released: EPS: Rp27.45 (vs Rp18.42 in 3Q 2022) Nov 02
Second quarter 2023 earnings released: EPS: Rp19.55 (vs Rp8.59 in 2Q 2022) Jul 27
Full year 2022 earnings released: EPS: Rp70.74 (vs Rp52.12 in FY 2021) Mar 31
Third quarter 2022 earnings released: EPS: Rp18.41 (vs Rp19.04 in 3Q 2021) Nov 23
すべての更新を表示
Second quarter 2024 earnings released: EPS: Rp23.16 (vs Rp19.55 in 2Q 2023) Aug 02
Director recently sold Rp79m worth of stock Jul 10 PT Siloam International Hospitals Tbk, Annual General Meeting, May 30, 2024 May 08
Consensus EPS estimates fall by 11% Apr 30
Now 21% undervalued after recent price drop Apr 26
Full year 2023 earnings released: EPS: Rp93.27 (vs Rp53.74 in FY 2022) Mar 28
Price target increased by 7.6% to Rp2,804 Mar 27
New minor risk - Share price stability Dec 01
Investor sentiment improves as stock rises 19% Nov 30
Third quarter 2023 earnings released: EPS: Rp27.45 (vs Rp18.42 in 3Q 2022) Nov 02
Price target increased by 9.0% to Rp2,347 Oct 31
Second quarter 2023 earnings released: EPS: Rp19.55 (vs Rp8.59 in 2Q 2022) Jul 27
New minor risk - Share price stability Jun 15
Investor sentiment improves as stock rises 15% Jun 07
Price target increased by 10% to Rp1,654 May 03
Price target increased by 14% to Rp1,503 Apr 11
Investor sentiment improves as stock rises 15% Apr 04
Full year 2022 earnings released: EPS: Rp70.74 (vs Rp52.12 in FY 2021) Mar 31
Price target increased to Rp2,593 Dec 10
Third quarter 2022 earnings released: EPS: Rp18.41 (vs Rp19.04 in 3Q 2021) Nov 23
No independent directors Nov 16
Consensus EPS estimates increase by 29% Nov 02
Consensus EPS estimates increase by 29% Nov 02
Price target decreased to Rp1,253 Sep 30
Consensus EPS estimates fall by 26% Aug 31
Now 21% undervalued Jun 17
First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat May 02
No independent directors Apr 27
Consensus forecasts updated Apr 13
Investor sentiment improved over the past week Apr 08
Consensus forecasts updated Apr 07
Investor sentiment improved over the past week Nov 27
Second quarter 2021 earnings released Aug 04
Price target increased to Rp8,817 Aug 01
Consensus EPS estimates increase to Rp246 Jul 30
Investor sentiment deteriorated over the past week Jul 29
Investor sentiment improved over the past week Jul 12
Consensus forecasts updated May 04
Price target increased to Rp7,050 Apr 29
Full year 2020 earnings released: EPS Rp71.52 (vs Rp208 loss in FY 2019) Apr 03
Price target lowered to Rp5,880 Feb 05
New 90-day high: Rp6,000 Jan 05
New 90-day high: Rp5,775 Dec 15
New 90-day high: Rp5,025 Nov 28
Third quarter earnings released Oct 28
PT Siloam International Hospitals Tbk(IDX:SILO) dropped from S&P Global BMI Index Sep 21
New 90-day low - Rp4,450 Aug 24
Price target lowered to Rp6,606 Aug 01
New 90-day low - Rp4,800 Jul 28
Siloam International Hospitals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史 IDX:SILO 収益、費用、利益 ( )IDR Millions 日付 収益 収益 G+A経費 研究開発費 30 Jun 24 11,925,106 1,022,194 2,564,059 0 31 Mar 24 11,563,310 975,347 2,423,556 0 31 Dec 23 11,190,511 1,211,283 2,369,046 0 30 Sep 23 10,832,121 1,106,185 2,269,370 0 30 Jun 23 10,390,058 989,559 2,214,600 0 31 Mar 23 9,950,417 846,820 2,174,053 0 31 Dec 22 9,518,012 696,495 2,154,189 0 30 Sep 22 9,169,880 591,385 2,188,528 0 30 Jun 22 9,153,148 581,729 2,185,617 0 31 Mar 22 9,304,933 629,511 2,221,306 0 31 Dec 21 9,381,891 674,117 2,218,108 0 30 Sep 21 9,252,324 696,908 2,056,042 0 30 Jun 21 9,235,701 548,898 1,900,623 0 31 Mar 21 7,965,652 243,863 1,746,149 0 31 Dec 20 7,110,124 116,163 1,677,442 0 30 Sep 20 6,803,525 -430,447 1,694,501 0 30 Jun 20 6,154,173 -473,708 1,733,235 0 31 Mar 20 6,750,300 -325,906 1,753,850 0 31 Dec 19 7,017,919 -338,772 1,735,371 0 30 Sep 19 6,784,349 56,070 1,672,004 0 30 Jun 19 6,493,033 46,132 1,649,209 0 31 Mar 19 6,228,319 19,018 1,639,836 0 31 Dec 18 5,964,650 16,182 1,580,488 0 30 Sep 18 5,802,446 33,676 1,511,014 0 30 Jun 18 5,644,061 41,649 1,441,798 0 31 Mar 18 5,465,301 53,645 1,392,874 0 31 Dec 17 5,305,996 93,566 1,316,813 0 30 Sep 17 5,243,537 63,333 1,284,599 0 30 Jun 17 5,123,947 43,387 1,235,370 0 31 Mar 17 5,202,418 85,800 1,207,450 0 31 Dec 16 5,168,363 85,901 1,188,977 0 30 Sep 16 4,955,349 85,449 1,142,882 0 30 Jun 16 4,711,979 91,715 1,097,162 0 31 Mar 16 4,421,569 76,382 997,373 0 31 Dec 15 4,144,118 70,396 935,312 0 30 Sep 15 3,938,644 87,931 884,222 0 30 Jun 15 3,759,900 73,763 836,441 0 31 Mar 15 3,565,936 79,492 813,739 0 31 Dec 14 3,340,793 71,843 752,411 0 30 Sep 14 3,089,078 84,040 696,332 0 30 Jun 14 2,870,114 74,031 638,249 0 31 Mar 14 2,670,816 49,588 604,969 0 31 Dec 13 2,503,600 49,870 560,865 0 30 Sep 13 2,354,656 24,597 479,644 0
質の高い収益: SILOは 高品質の収益 を持っています。
利益率の向上: SILOの現在の純 利益率 (8.4%)は、昨年(8.5%)よりも低くなっています。
過去の収益成長分析
収益動向: SILOの収益は過去 5 年間で年間53.6%増加しました。
成長の加速: SILOの過去 1 年間の収益成長率 ( 15.2% ) は、5 年間の平均 ( 年間53.6%を下回っています。
収益対業界: SILOの過去 1 年間の収益成長率 ( 3.3% ) はHealthcare業界-1.7%を上回りました。
株主資本利益率
高いROE: SILOの 自己資本利益率 ( 12.6% ) は 低い とみなされます。
Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.